SERT-dependent inhibition of serotonin uptake in mouse synaptosomes
Biochemical assay · Midbrain synaptosomes from 8–12-week-old male WT Ile172 and SERT Met172 mice on a congenic C57BL/6J background; both SERT alleles share the 129-derived E39R152 haplotype. [1]
Citalopram inhibited radiolabeled serotonin uptake with lower potency in Met172 than WT preparations. Basal expression and saturation uptake did not significantly differ; paroxetine inhibition was preserved.
| Endpoint | Reported result | Reference |
|---|---|---|
| Citalopram inhibition of [3H]5-HT uptake | KI WT: 2.07 ± 0.05 × 10^-8 M; Met172: 7.91 ± 0.05 × 10^-6 M; n=4 per genotype and condition | [1] |
| Paroxetine inhibition and baseline controls | Control comparison Paroxetine KI: WT 2.00 ± 0.03 × 10^-9 M; Met172 1.80 ± 0.04 × 10^-9 M; n=4 per genotype and condition. SERT expression: P>0.05, n=5/genotype; saturation transport: P>0.05, n=6/genotype. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Varying inhibitor concentrations; 20 nM [3H]5-HT
- Exposure duration
- 10 min at 37 °C
- Method
- Competition uptake assay in isolated synaptosomes
- Co-treatment
- No combination treatment; paroxetine and fluoxetine were separate comparator inhibitors.
- Reported limits
- Exact inhibitor dilution series and assay vehicle not specified in the read methods; ± statistic for competition KI values is not defined in the caption.
Methods and source locations
Compound reported in the paper: Citalopram hydrobromide; Compound label in the paper: citalopram HBr
Evidence for the reported citalopram hydrobromide material; no Adooq lot validation, salt conversion or isolated-enantiomer equivalence.
Published PDF pp. 1734–1737: Drugs; Synaptosomal 5-HT Uptake; Results; Figure 1a–c and caption
Citalopram inhibition of [3H]5-HT uptake: Reported Figure 1c caption values; ± meaning not explicitly assigned there. These are inhibition constants, not treatment doses. — Published PDF pp. 1734–1737: Drugs; Synaptosomal 5-HT Uptake; Results; Figure 1a–c and caption
Paroxetine inhibition and baseline controls: Figure 1a–c; expression normalized to β-actin; saturation uptake uses whole-brain preparations and 1 μM paroxetine to define nonspecific uptake. — Published PDF pp. 1734–1737: Drugs; Synaptosomal 5-HT Uptake; Results; Figure 1a–c and caption